Skip to main content

Table 2 List of iBEAt exclusion criteria (see also additional file 3.0)

From: Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol

Permanent dialysis Current metastatic malignancy
Renal transplantation Current malignancy with expected survival < study follow up period (4 years)
Known clinical history of urinary obstruction on renal US Melanomatous skin cancer < 5 years ago (fully resected melanoma > 5 years ago, i.e. surgical cure, can be recruited)
Post-voiding residue over 100 ml, or pyelectasis Use of investigational drug within 1 month prior to screening
Known clinical history of aortic endoprothesis at the renal level Current pregnancy
Known current or clinical history of renal or urinary tract malignancy Use of antiretroviral medication
Biopsy proven non-diabetic primary renal disease History of Hepatitis B or Hepatitis C
Autosomal dominant polycystic kidney disease (APKD) Significant comorbidities with life expectancy of < 1 year
Cirrhotic liver disease or non-cirrhotic chronic liver disease where alanine aminotransferase > 2 x upper limit of normal Standard contrast enhanced-MRI exclusions (e.g. cochlear implant, aneurysm clips, claustrophobia and known allergy to Gadolinium contrast)
Renal stones causing CKD Any other significant disease or disorder which, in the opinion of the investigators, may either put the patient at risk because of participation in the study, or may influence the result of the study, or the patient’s ability to participate in the study